Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.57% is 38% below its 5-year average of 4.16%, near the low end of its 5-year range (2.57%–5.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.98% below its 12-month average of 2.86%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.57%.
DEBT TO ASSETS RATIO
2.57%
DEBT TO ASSETS RATIO AVG TTM
2.86%
DEBT TO ASSETS RATIO AVG 3Y
3.53%
DEBT TO ASSETS RATIO AVG 5Y
4.16%
DEBT TO ASSETS RATIO AVG 10Y
3.49%
DEBT TO ASSETS RATIO AVG 15Y
2.51%
DEBT TO ASSETS RATIO AVG 20Y
2.30%
CURRENT VS TTM AVG
-9.98%
CURRENT VS 3Y AVG
-26.99%
CURRENT VS 5Y AVG
-38.06%
CURRENT VS 10Y AVG
-26.26%
CURRENT VS 15Y AVG
+2.62%
CURRENT VS 20Y AVG
+12.04%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+2760.65%
vs the sector median at left
HealthStream, Inc.
Market Cap
$914.73M
Debt to Assets Ratio
2.57%
TTM Avg
2.86%
3Y Avg
3.53%
5Y Avg
4.16%
Market Cap
$921.06M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$929.83M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$934.79M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$887.99M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$884.97M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $914.73M | 2.57% | 2.86% | 3.53% | 4.16% |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | 0.18% | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $923.53M | 0.13% | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | 0.01% | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | 0.04% | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $887.50M | 0.39% | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 0.01% | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $952.91M | 0.16% | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | 0.02% | N/A | N/A | N/A |
Debt/Assets
2.6%
Debt/Equity
0.04
Current Ratio
1.06
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.57% |
| 2026-03-31 | 2.67% |
| 2025-12-31 | 2.82% |
| 2025-09-30 | 3.06% |
| 2025-06-30 | 3.18% |
| 2025-03-31 | 3.18% |
| 2024-12-31 | 3.95% |
| 2024-09-30 | 3.57% |
| 2024-06-30 | 3.76% |
| 2024-03-31 | 3.81% |
| 2023-12-31 | 4.64% |
| 2023-09-30 | 4.22% |
| 2023-06-30 | 4.42% |
| 2023-03-31 | 4.49% |
| 2022-12-31 | 4.69% |
| 2022-09-30 | 5.00% |
| 2022-06-30 | 5.19% |
| 2022-03-31 | 5.27% |
| 2021-12-31 | 5.98% |
| 2021-09-30 | 5.43% |
| 2021-06-30 | 5.42% |
| 2021-03-31 | 5.52% |
| 2020-12-31 | 5.69% |
| 2020-09-30 | 6.02% |
| 2020-06-30 | 6.15% |
| 2020-03-31 | 6.25% |
| 2019-12-31 | 6.28% |
| 2019-09-30 | 6.53% |
| 2019-06-30 | 6.73% |
| 2019-03-31 | 6.70% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 9.35% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.55% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.10% |
| 2010-09-30 | 0.26% |
| 2010-06-30 | 0.36% |
| 2010-03-31 | 0.18% |
| 2009-12-31 | 0.95% |
| 2009-09-30 | 1.03% |
| 2009-06-30 | 1.50% |
| 2009-03-31 | 2.00% |
| 2008-12-31 | 2.67% |
| 2008-09-30 | 2.40% |
| 2008-06-30 | 2.76% |
| 2008-03-31 | 3.19% |
| 2007-12-31 | 3.55% |
| 2007-09-30 | 4.21% |
| 2007-06-30 | 4.74% |
| 2007-03-31 | 0.61% |
| 2006-12-31 | 0.69% |
| 2006-09-30 | 0.86% |
| 2006-06-30 | 1.01% |
| 2006-03-31 | 0.99% |
| 2005-12-31 | 1.08% |
| 2005-09-30 | 0.97% |
| 2005-06-30 | 1.07% |
| 2005-03-31 | 0.49% |
| 2004-12-31 | 0.19% |
| 2004-09-30 | 0.22% |
| 2004-06-30 | 0.04% |
| 2004-03-31 | 0.08% |
| 2003-12-31 | 0.14% |
| 2003-09-30 | 0.18% |
| 2003-06-30 | 0.22% |
| 2003-03-31 | 0.25% |
| 2002-12-31 | 0.33% |
| 2002-09-30 | 0.38% |
